NCT05253131 2026-02-11Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for SarcomasUniversity of Alabama at BirminghamPhase 2 Not yet recruiting41 enrolled
NCT07298083 2025-12-23DoD Award NF230020 Identification of Metabolic Markers and Statistical Prediction of MPNST for Rapid Diagnosis and Assessment of Surgical MarginsM.D. Anderson Cancer CenterNot yet recruiting60 enrolled